Health Innovators
Health Innovators

Episode · 1 year ago

Relationship building, pivots, and making a difference w/ Hila Goldman-Aslan


Hila Goldman-Aslan and her partners entered the start-up arena in an environment that encouraged healthcare innovation, actively sought out young minds and fresh ideas, and then deepened their support with funding.  The result: a fully functional AI imagining analysis solution that’s currently being used on the frontlines of today’s pandemic.

In an industry that sees a nearly 95% failure rate for adoption, DiA Imaging Analysis may have had a supportive boost, but it took ingenuity, tenacity, and an understanding of the importance of relationship building to confidently present their solution to some of the biggest players in the healthcare technology industry - and then successfully bring it to market.

In today’s episode, Hila recounts her company’s path to adoption, and the pivot they made to adjust for the COVID-19 pandemic. Our listeners will enjoy her candor and passion for healthcare innovation. 

Here are the show highlights:

  • The trick for partnering with big corporations like IBM and GE (6:01) 
  • Why it’s foolish to think your product needs to be polished and perfect before pitching it to investors (9:04) 
  • How to save millions of dollars on features and functionality that nobody wants (11:46) 
  • Why it’s easier than you think to get in front of the right people at any company (14:30) 
  • Tweaking this one little thing will help your product sell like hotcakes (20:15) 
  • How the pandemic will make unusual ideas like AI more palatable (23:28)
  • The reason physicians should celebrate AI instead of fearing it (26:15) 
  • Why aggressively trying to sell backfires on you and what to do instead (33:58) 

I've spoken with dozens of health innovators, and nearly everyone is trying to figure out their best pivot strategy. But they don't know what to change, how to pivot, or if their new pivot strategy is the right move.

So I went into overdrive putting together a clear, actionable 5-step worksheet that will help you quickly define your most viable and profitable pivot path through the COVID crisis. And I’m giving it to you for FREE — no strings attached at

Guest Bio:

Hila Goldman-Aslan is CEO and Co-Founder of DiA Imaging Analysis, a company that uses AI-based technology to help make ultrasound analysis smarter and more accessible to everyone in the healthcare field. 

Holding a Master of Law (LLM) from Tel Aviv University, specializing in Commercial Law and a dual bachelor's degree in Law (LLB) and Business Administration (BBA), Hila knows how to get things done. Her determination and passion has served her well on her journey through the med-tech landscape and helped fuel DiA’s successful launch into the AI market.

If you’d like to discuss the application possibilities of AI in imaging, or have additional questions or insights you’d like to discuss with Hila, you can reach at or by visiting DiA Imaging Analysis at

Welcome to Coiq, where you learnhow health innovators maximize their success. I'm your host, Dr Roxy, founderof Legacy DNA and international bestselling author of how health innovators maximize market success.Through canded conversations with health innovators, earlier, doctors and influencers, you'll learn howto bring your innovation from idea to start ups to market domination. Andnow let's jump into the latest episode of Coiq. Welcome back to the showcoiq listeners, for another episode of Our covid pivot series. Today I amspeaking with Hela Goldman Ashland, with Dia Imaging Analysis. Welcome to the show, Heala. Hi, thank you. Thank you for having me. Solet's start off by telling our listeners a little bit about your background and whatyou're doing these days. Okay, so I'm as you managed to seal andCo founders the imaging houses and what we are doing. You say ai foraltrasound images, and I started the company with my partner we had. She'sjust C deal of the company. We actually are three women founders out offor founders in the company and the two of us are leaving the company.Full time in the company and then yeah, we started these companies and incubator companyhere in Israel and the headquarters here, and we have also substand subsidiary inthe United States. And Yeah, they very busy these days. Sowhat were you doing from a business standpoint? You know what problem and need youwere meeting prior to Covid and then let's talk about how you might havepivoted that some you know, now under the new crisis that we're facing.So yeah, so when you're talking about ultrasound, immediately you are thinking aboutthe babies and actually today you are doing you are using auto sound also almostto any anatomic area in the body, and ultrasound is a very safe imagingdevice compared to CD or x Ray that has radiation, or MRI, whichis very expensive. So the use of ultrasound during the last daycake or eventhe last five years increased dramatically. And what you're seeing today is those newhandheld portable autosound devices that are being used all over in new areas that werenever been used before, like Americancy Room. I see you in turn, littlemedicine, per medics use autosund today, and what we saw is a big, big that gap between the accessibility of those ultrasound devices. That becomingmore and more accessible, but still the analysis of those images is being doneby visualist and estimation, and not only... the new areas of auto sound, what we call point to scare, alto sound and segment, but alsoin the dedicated ultrasound units like their ideology and cardiology. Still The virability betweenposition is very, very high because there are mainly just looking at the pictureand trying to analyze the images, and we decided that we want to addressthis issue and eliminate or reduce the virability between position by providing those kind ofAI solution that will help them analyze those images in the very objective, quickand accurate way. Uh Huh, incredible. So let's talk about what stage ofthe innovation process you were in or you are in. So we startedwith cardiac culture sound because you know, hard disease are the number of arebecause of death in the world and actually, when we are talking with even theemergency rooms in the big hospitals, they are saying that about thirty percentof the people entering the emergency room are complaining of symptoms that can be relatedto heart issue. And we figure out that it's very difficult to analyze theheart with alta sound, even in the dedicated ultrasound or cardiac unit, becausethe heart is a moving organ and still the image of ultrasound is very noisycompared to Mri and city also when you take the image compared to Mr ctx Ray, where you posing the patient and the device with the authors andactually put the transducer on the patient body and trying to find the right image, which is also very subjective and depends on the user experience. So forus, heart was the first day as segment that we looked at and wedeveloped a set of solutions to help them find all kinds of clinical indication thatthey are looking for by visual estimation and find it automatically and vary in anobjective way. And those kind of solution, what we call the V A toolbox, already had FDA approval and see mark. So we started to sellthem to the market last year and the way that we are doing it isthat we partner with channel partners like ultrasound companies and health care tea companies thatadd these solutions to their autosound devices and health care tea system so any physitioncan actually use it when they are doing the process of taking those images.So we have partner with companies like GE and IBM and Connie Coming Alta andand we actually seeing those day Ai Solution being used even today with the cobbyin the front line. so that's really impressive. Those are definitely some bigbrands right, some really well known brands around the world, not just youknow and Israel or in the united it states. And so let's just kindof talk about for our listeners a little bit of how did that come tobe? I'm sure all of our listeners...

...want to know how did you landsomeone like IBM andnge to be your partner? So it's see, it's a verylong process. You have to build this relationship. Like everybody knows,it's not easy to work with any of these corporate companies and I think thatwhen we started, we write at the beginning, they think, even beforewe had a finalized product, even when we waited for the FDA approval andto have this process, we already started to talk with those channel partners andthat also helped us to understand the market and the needs and what they're seeingas an advantage and when and how they are going to use that kind ofsolutions. So I think that the main thing that I learned is to talkwith those channel partners as early as you can. It also help you withthe product and to design it correctly, to understand, not only from physiciansbut also from the industry, what they are seeing, what they are hearing, and and then you build this relationship, because you are getting back to themevery few weeks and tell then your progress and what you're doing, andand meeting them at conferences to their of course, is really, really difficultto do that, but right back then we did that and all the timemeeting more people in the in the corporate and in this specific unity to workwith. And once we had that kind of a solution ready to implement,I think everything was also from them, their sire, ready for them toaccept it. And another thing that I think that happened is the change inthe market. So when we started, AI was like a big word thatnobody knew, knew what you're going to do with it. And also thosewe cooperate, the thought that maybe we can develop a bit by ourselves,maybe we don't need somebody, maybe maybe the market are not ready to acceptor to pay more for AI solution. And definitely we are seeing in thelast two or three years a big change in both segments. Both we seealso the end user, which are the hospitals and clinic sensosition, having evenasking when they are buying new system on their existing system, asking their providerswhat do you have now with ai? And I think it's really relating alsoto change in generation and those new positions. New Doctors are used to work withtechnology, are looking for technology, want to use their ten technology thatit out there. Also, I see it from the vendors side. Theyare actually definitely say that they want to a partner with her party. Isthat sended? They cannot develop everything by you by themselves. Yeah. So, so let's go back to what you were saying of you know, startingthose conversations with channel partners and, you know, people that are part ofthe ecosystem really early, because I think...

...that's very interesting. You know,a lot of health innovators tend to think that they need to have something,you know, polished and perfect before they get in front of anyone, especiallysome of these bigger entities. You know that they have a tendency to believewe're going to have really high expectations for a startup. So let's kind ofjust talk a little bit about that. What were some of the considerations andhow did that evolve? So I think there's a start up. There isa big different and sure we will talk a little bit more about it later, about how where you are prepared, for investors, for example, comparedto your channel partners or customers. I think that there is more acceptance inand we saw that with our channel partners, that we started the conversation jury early, because they also want to be aligned with what's going on and whatstartups are doing and they are looking for this kind of a relationships and connection. So it's not for them. Okay, and if you are too early,they will say to you, listen, your too early. We will notdo anything before you have, I don't know, clinical realidation at theapproval or whatever. So you will get a lot of feedback also of whatthey are thinking and is more or less important. So I think we wechannel partners and customers. They think you probably I would not go to allof them at once if you's very time consuming. I will pick those whoare probably the leading one and the ones that you are really targeting. Andwith investors, I think it's different, different thing with investors. You haveto come prepare. I don't believe in just doing introduction just to get toknow you. You have the time with investors. Usually they will have askedyou very specific question and and you don't have the answer at that point.You are using opportunities for each better to reach out to investors when you're readyand it if you are in late, early stage around Berra, be readyfor first for those questions and with all the material sidewise, I think ifyou are missing the opportunity. Yeah, so we'll talk about that a littlebit too. So I think that what you just said is just really importantfor our listeners to kind of grab a hold of. Is that in thisis something that I advocate for quite a bit, is this idea of cocreating our solutions with our customers, with our vendor partners, and, youknow, bring them along in that process early on. There's two things thatI've seen happen as a result of that that you know I'd love to hearyour thoughts on. Is. One is that you know a lot of timesit saves the innovator millions of dollars on features and functionality they thought were goingto be so important, but through that dialog and that Co creation process theyrealize that it might have been really important to them, but it wasn't soimportant to their target audience. Or do...

...those partners, and so they cansave that that time and save those millions of dollars, not wasting on thatto maybe have that for their go to market strategy. And then, ofcourse, you know, if you're building a solution with folks that are partof your your know your customer segments. Is that your your Roi is goingto tend to be higher, right, because you know that you're building somethingthat they want, because they told you what they want and they were partof that process. Yeah, doesn't. We actually had these experience several yearsago when we started to develop something and once we talk about with the industry, realize they it's it's really a niche and it's better not to put aneffort. We put this development on home and we started to Associa. Somebodywill want back. So we have something like your product, dipe or whatever, but we are not continue. We are not going to continue. Youdon't yeah, yeah, so so let's also talk about access to those folksright. So how in the world did you even have the chance to getin front of, you know, the right people at those companies? SoI good. Recently, I don't remember who it was that talk about marketingand about business model and we you said something like I'm envy the ones thathave be to be relationship, because you know who you are looking for,you are needed for the product manager and the business development are you know thetitle and you know who you are looking for, versus when you selling toconsumers, which is much more difficult to get to them user at that point. So I think that we time we understand. We understood who are there, usually the decision makers and who are involved in the process of deciding whatto add and who to partner with and what they're looking for. And inArche was clinical specialties and product managers and Business Development Guide even sells, andsometimes it even came from the rdtens that had a need. And then didthe student that it's not part of the road map and probably it will givethem a very big different areasure in and advantage. And I cannot tell youthat in each partner segment is was the same people right, but I thinkthat the best way to target them, of course, is going to thosestraight shows and even, you know, presenting yourself with the Book and sayingI'm looking for people that are doing that, this and that, and very quickly, you know, we are very everybody's connected to everybody else, andthen somebody there will a you're okay, I think you should up to thisperson and need to disperson things, that he's not the right person, whowill reserve you through somebody else. So I've actually you get through the rightpeople. I think it's much easier than... think. HMM, person,it sounds like persistence is key. Yeah, never given up. Hey, it'sDr Roxy here with a quick break from the conversation. Are you tryingto figure out what moves you need to make to survive and thrive in thenew covid economy? I want every health innovator to find their most viable andprofitable pivot strategy, which is why I created the covid proof your business pivotkit. The pivot kit is a step by step framework that helps you findyour best pivot strategy. It walks you through six categories you need to examinefor a three hundred and sixty degree view of your business. I call themthe six critical pivot lenses. As you make your way through this comprehensive kit, you'll be armed with the tools, tips and strategies you need to makesure you can pivot with steed without missing out on critical details and opportunities.Learn more at legacy type and DNACOM backslash kit. So you were talking aboutthe changing and market conditions and I want to spend a little time on that, because bringing a disruptive innovation to market or something that's radical, is verydifferent than bringing it something that is just an incremental innovation. Both are incrediblyvaluable and both have their own place, but it's a different strategy and adifferent path that you'll need a Akee. And so it sounds like when youfirst enter the market that it was really radical and disruptive, and so let'stalk about some of the the challenges that you faced before those market conditions changedand then how that really open the door or the floodgates for you. SoI think that the beginning, as and I think a lot of the startupcompanies at the early stage has a very big idea and usually a lot ofpeople tell them you are crazy, you should that and it wouldn't work,and and so forth, and so I think that maybe it's, you know, we had a very passionate idea that we doesn't make sense that in ultrasoundyou're still looking at the picture and saying, I think that I'm seeing this andthat, and every time somebody tell yeah, but we know, Iknow. I back then it was like the most expert ones to say yeah, but I used to it and and I always will. Also always tellthem, but it took your ears to understand what to look for. Andnow with technology we can, we can make it more accessible and more smarterto do. We know those, know these ones and the ones that areand back then it wasn't the alto sound, wasn't in points care. So wedon't market involving and we did AI getting like more acknowledgement and the awareness. I think that came together and gave us the big push eventually to tobe able to implement it and actually have the end. You know, thefirst one and the first two ones are the hot toughest, but then yousee the results, and now definitely we see that. As I mentioned,we are working with g on the handle,...

...also sound device. Today, withthe coverage, we see physician use our AI in the front line andand you know, I think and mentioned it before, but I'm always sayingthat the first time that we actually in the company were very excited and veryproud and actually had tears in our eyes, is that we saw a physician,it's South Africa, using our AI, tweeting about that, saying how howit helped her. And you know, for us it was like that.That's it, that's the top for us and that's so exciting to seethat that eventually, you know, physician are using it, getting value outof it, helping them in the decision making and and and that was forus to say, okay, it was all work for to wait for that, and I always say that the same in life, you know, youcannot say that you are happy all the time. You have happy moments andin the startup it's the same way. You have a happy moments, happypointing in the startup that you say, okay, this is why I'm here, this is why we are why we're doing that. Yes, yes,absolutely so. Let's talk about that. Right, keep down this path ofa changing market conditions. Right because you said, you know, you firststarted and people were like, what is this ai thing and how would thatpossibly prove valuable? And then the market kind of caught up and so thatwas could a pivot opportunity for you. And then we're thrust into all thingscovid really over the last couple of months, which is another opportunity for pivoting.So let's talk about you know where we're. What was that like foryou when this first started to happen? What were like that early stages ofthat process of thinking I need a pivot. And then let's talk about what's whatare some of the pivots that you've done? And you know, whenI use the word pivot, you know it could be where I changed abusiness model right, something really major, or it could be just pivoting aroundmessaging, and that's a lot more surface, reframing how my solution might meet adifferent need. So talk about that a little bit for our listeners.So yeah, so we didn't bet anything about our business model, but wedid do something upgrade or updated to our messaging and we did see very quicklythrough our charnel partners did. They are selling even more and today end usersto those those in the front line in point to scare all the song theirsystem. We'd our solution. So very quickly we understood that we are partof Dosh and, you know, endemic. We are giving value to those frontliners and and we are partner and we need to do to make everybodyknow that there is an advantage of using AI in the front line up.So, yeah, very quickly we design a web page all around covid andyou can see it in our website,...

...and prepared for all of our channelpartners in one pager, collecting all the information that we got during the lastfew weeks about the important and the use of our ai because those channel partnersthat are in front of them users, which are the hospital of the clinics, we want in them to have those messages in front of them to helpthose front liners understand how they can use our solution and how it can helpthem. Today, with the Covet, for example, we talked about itthat we have those solutions for hearts, for the cardiac solutions, and wesaw a lot of the information and studies, even from China and Italy, showingthat as about thirty or forty percent of the people that eventually died fromCovid I died from issue relating to heart issues, and everybody think lungs,but it's not only lungs. The lungs actually affect the heart and then yougetting all kinds of issue around the heart and the ability to use our assolutions for the tree I've and from monitoring those patients, they see the treatmentgetting them better or worse when you cannot bring c Tmr to these areas andauto sound is very small, it's hard to eat, very easy to cleanand and it's very accessible in terms of looking at the body, inside thebody and see what's going on. So having those ai solution and those sitationand the front line are not radiologists there are not expert in taking images andbe able to help them and say, okay, put the transiser, lookin the heart, press one click, see that what the Ai telling you, and then you can monitor the patient. We even talk to one of thebiggest house will done in New York and they say we are opening nowa tent outside and using ultrasound to scream who who gets to get in thehospital, who stayed out? Wow, and and for that to have thosekind of a solution that that's mean. Mainly what we're doing now is isaddressing these messages and giving them a lot of information through those two our channelpartners at the website other social media, trying to educate the market about theuse of our ai in the stage and in this pandemic. So I thinkthat also another thing that they see in terms of market or marketing is thattheir awareness of those ai solution in imaging, even after this outbreak, will bein a different level. Before we knew that this, you know,point of scare all to son an AI is emerging and people understand more andmore. Now we are in a different like in the different times. Nowthere is a peak now, you know, everybody stressful and want to get educated. Their awareness will be in a...

...different level after this outbreak. Sowe're expect to get even more interested after that. So how humbling to knowthat something that you and your team innovated is really valuable on the front linesof this global pandemic. Like, who would have ever imagined three four yearsago that you would be able to have this kind of impact on people's lives? And isn't that why we're all doing what we're doing? Anyway right isto really be able to help people in a way that their had it thehealthcare system hasn't helped them previously. I think this is the advantage of workingat startup company in the healthcare area. I think also when we interview andemployees to the company in candidates, the main thing that we hear in allthe time is that, you know, I used to work in a gamingcompany, I used to work in and and for me, you know,the meaning of understanding that what I'm developing eventually we go to different reasons handseventually affecting the patients is, you know, what, if what? What help? You woke up in the morning, you say I have a great jobbecause I actually make a different yeah, yeah, absolutely. You know,it's certainly unfortunate that it's taken a global pandemic to elevate the different usecases in value of digital health and technology and AI and, you know,all of the different solutions that we have. That has been available for a longtime. But you know, for a variety of reasons, you know, we haven't seen the type of adoption that that we like or that,you know, for folks like you and I know, could be really valuable, and so I think that, you know, it's interesting to see theseuse cases of how, you know, technology in your solution, with Ai, can really do things that humans don't need to do to free up todo the things that only humans can do. Right. Yeah, we also alwayssay that we are not going to replace those positions. We are actuallygiving them another instrument in their tool box. If they had blood dish and theyhave UCG and they're all kind, now they have a ai that theycan use to make better decisions, to give them confident about the decisions,and I don't see that we are replacing them. As you mentioned, youare human interaction that you can replace and I don't think they who will beable to replace it, at least not be in the near future. Rightand yeah, I also think that, in terms of investors and he seeswhat we what we will see after this outbreak is more interest to invest inthe digital health companies and we will see...

...more becus that have never thought ofinvesting in healthcare, but now I was saying, Oh, really not,I understand the value and and I want to be part of these days.Yeah, yeah, I couldn't agree with you more so. The other thingthat I wanted, you know, just kind of touch on is one ofthe big value propositions of ai in any application is really scalability, efficiency andbe able to do something fast. And Wow, what you know, thosethree attributes aren't needed anymore than they are now right like like. We beable to act fast, we need to be able to scale and we needto be efficient in order to continue to meet the needs and the burden that'sbeing put on healthcare systems. So what an incredible opportunity we have to leveragetechnology like yours and meeting a need. Yeah, definitely, I think thatthe AI is just at the deeper the ice now and I think the nextdecade we will see so many implementation of addressing what you just mentioned about efficiencyand accuracy and making those physicians, you know, be more efficiency in termsof making decisions and the time that they're spending, because right now they areearspended by trying to mark things and and look for things, are calling anexpert and then waiting for the expert a sending the patient to another except wheneverything, you know, will be with it with Ai Solution, I thinkthe the health systems, of course, will be more efficient and definitely efficiencyreflects the patients management. Yeah, yeah, and I think, you know,time will tell, but I don't know that we will ever go backto the current state of healthcare innovation before this pandemic. Will we be asfar as we are now? Who knows? You know, we'll see, butI definitely think that, you know, the silver lining in this is thatit is certainly a springboard for greater awareness, like you mentioned, ingreater awareness is is going to you know, now we, all of us,are very stressful and everybody trying to understand where we are going and whenwe're going to get back to normal. First Time. I'm not sure wewill ever get really back to what we were before. Think that will.We understood that already, but in terms of awareness, definitely different story thanit was before. Sure. So let's talk about the Israeli ecosystem and supportfor healthcare innovation. You know, this is something that you and I talkedabout previously and I think it's definitely a worth mentioning here for our listeners.You know, we talked about this. Ninety five percent of innovations that goto market fail to reach any adequate level of customer acceptance or Financial Roli,and you had some really great feedback in...

...response to that conversation about what's differentof where you're living and where you're innovating. So so give us some insight fromwhat's going on there. So, yeah, Israeli used to being concernedand, as you know, is the startup nation. And today, Ithink in then every given time you have six thousand and startups and the populationis eight point five million people, which is been ratio hees like. Ithink it's even very similar to the silly the convoy, I think maybe thesecond, second one in the world. It part of it is, then, also government support, and the government in Israel is very, very pushingin startups to emerge, putting a lot of investments in things that they knowthat the ninety nine percent of the case it will not emerge, and puttingsubstantially amount of money, like half a million dollar, even one hundred milliondollars for you to start, even Fiftyzero to you to start and doing something. There's a so many programs and so many applications that can be applied,you can apply for and where the government is pushing you to to actually try. And it's fine if you fell because they know that the statistic is thatyou're going to fell and it can apply again for different things that you aredoing also, and when you are part of the university and and and alsothe university. It urged you to try and apply for those grants in orderto try to and get out of what you developed with something. So Dais a very, very similar example. And my partner, because she shestudy or second degree in one of the biggest university here in Israel, andshe had a great idea with this, say ai for ultrasound. I mether back then and an end we said, okay, well, how can westart? And we say, okay, let's apply for government funding and weapply for the incubator program here in Israel that you said to two threeyears program that give you money and expert and more of an accelerator environment foryou to try it on and see how you work with that. And thisis what gave us actually the push and the first opportunity to try to dosomething with this you know, invention or and it came out of the youknow, second degree and master degree of my partner. And and now lookwhat we are so and so, yeah, it's the environment here the ecosystem here, a lot of support from also the government, also the big companieshere that having our these centers and inviting start up to meet ups and allkinds of events. So and helping each other. I think that's also partof it. Yeah, that's incredible. It's really wonderful to see and inyour right there's certainly a lot of healthcare...

...innovation that is just flourishing over there. So, as we wrap up, a lot of our listeners are healthcareinnovators that are in the trenches day in and day out like you and experiencingthis covid crisis. What advice or other lessons learned do you want to sharewith them before we end? So I think the first thing, and wetalked about the Deliza Bach, is about messaging. Be Very sensitive about whatyou are posting, and you know nobody now wants to read about things thatare not really aligned with what all of us are going through. You haveto understand. You know, I'm I know that a lot of the peopleright now, in terms of statistic and don't have maybe even friends or familythat are sick from this virus, but there's a lot of sick people anda lot of family that are affected from that. So I think being sensitiveabout what you're writing, more educating the the audience then trying to really aggressivelysell. I you have to. I think that's the first thing that Iwould say. That is a very important think of what in your product andyou're offering can help and and user right now and if there isn't so,mainly invest more on your bit to be relationship and then to just go outand try selling something that right now people maybe not really interesting to to lookat. Yeah, and that that's what you mean. And and on theother hand, if there's an opportunity to change the business, Moll and andthink of a different of pivoting to different directions, and I think it shouldbe considered great. Well, another thing, and that a small thing. Ithink they also in terms of the your employees, I think very beingvery transparent and what's it's going on and why if you doing changes. Beingvery transparent with your employees is very important. You know, everybody wants to andbe together and everybody is having their own difficulties. We talked about alittle bit that. They're some peoployees with very small children at home trying tobe flexible there and give them the space of working early or late or whateveris needed, and because we are all of that together and we have tokeep staying strong together. Yeah, I think that leadership is more important thanever in really being able to be a great leader during this time and beinghuman and understanding, because we're all people at the end of the day.That's I'm yeah, yeah, well, thank you, Helen, so much, for sharing your wisdom with our listeners today. How do folks get aholdof you if they want to follow up with you? You know, throughour website. Also, I will leave you my email showing sure every Y, anybody wants to move it can reach... directly. I will be happyto to talk to anybody to each any help or want to learn more.Do you want to give your email address here, or do you want tohe la Hili at DIA and Middle Analysiscom? Excellent. Thank you so much.Great. Thank you. Thank you so much for listening. I knowyou're busy working to bring your life changing innovation to market and I value yourtime and your attention. To save time and get the latest episodes on yourmobile device, automatically subscribe to the show on your favorite podcast APP like applepodcast, spotify and stitcher. Thank you for listening and I appreciate everyone who'sbeen sharing the show with friends and colleagues. See You on the next episode ofCoiq.

In-Stream Audio Search


Search across all episodes within this podcast

Episodes (111)